Business

Secretary of State for Wales site visit

Secretary of State for Wales site visit.

articleCreo Medical Group PlcJuly 13, 20203/company/creo-medical-group-plc/news/secretary-of-state-for-wales-site-visit
Secretary of State for Wales site visit

About this update from Creo Medical Group Plc

[{"type":"text","content":"\n \n \n RNS Number : 8185S\n Creo Medical Group PLC\n 13 July 2020\n  \n \n \n \n  \n \n \n A non-material typographical change has been made to the ' Secretary of State for Wales site visit' announcement released on 13 July 2020 at 10.08 under RNS No 8076S.\n \n \n  \n \n \n The changes are identified with an asterisk (*). The full amended text is shown below.\n \n \n  \n \n \n  \n \n \n Creo Medical Group plc\n \n \n (\"Creo\" or the \"Company\")\n \n \n  \n \n \n Secretary of State for Wales site visit \n \n \n Simon Hart* MP shown plans for using Cool Plasma technology to combat COVID-19\n \n \n  \n \n \n Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of surgical endoscopy, announces that it hosted a visit from the Secretary of State for Wales, Simon Hart* MP, at its Chepstow Head Office on Friday 10 July 2020.\n \n \n  \n \n \n As well as showing the Welsh Secretary \n shown Creo's range of advanced energy surgical endoscopy products, the Company also gave a presentation on its Cool Plasma technology. Creo's Cool Plasma technology has a proven, high efficacy kill of bacteria, and is expected to be highly effective in the inactivation of viruses.  6 log (i.e. 99.9999%) kill has been shown on the most resilient bacteria, including MRSA. E.Coli, K.Pneumoniae and C. difficile. Initial research and third-party testing indicates a consistent view that Creo's Cool Plasma would inactivate (kill) the SARS-CoV-2 virus given its performance on relatively 'tougher' bacteria. \n \n \n  \n \n \n The presentation contained a video of the Cool Plasma technology and is available to view here:\n \n \n \n https://www.creomedical.com/2020/07/08/development-loan-for-plasma-sterilising-product/\n \n \n \n  \n \n \n On 2 July, the Company announced that it had secured a £2m loan from the Cardiff Capital Region to develop Creo's Cool Plasma technology as a method to kill bacteria and viruses and for sterilisation purposes. The five-year loan will ultimately support the creation of Creo's Plasma Division which will focus on the use of Creo's CROMA Advanced Energy platform to create safe environments \n through sterilisation and decontamination.\n \n \n  \n \n Secretary of State for Wales, Simon Hart said:\n \"It is fantastic to see Welsh compa...

More updates from Creo Medical Group Plc